XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Note 8 - Stock-based Compensation
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

8.         Stock-Based Compensation

 

Stock-based compensation expense for the three and six months ended June 30, 2023 and 2022 was classified in the condensed consolidated statement of operations as follows (in thousands):

 

  

Three Months Ended June 30,

  

Six Months Ended June 30,

 
  

2023

  

2022

  

2023

  

2022

 

Research and development

 $146  $174  $229  $548 

General and administrative

  1,482   1,270   2,666   2,470 

Total

 $1,628  $1,444  $2,895  $3,018 

 

As of June 30, 2023, remaining unrecognized stock-based compensation cost from all plans to be recognized in future periods totaled $17.4 million.

 

Restricted Stock:

 

Prior to the adoption of the 2020 Plan, the Company issued restricted stock. A summary of the Company’s restricted stock activity during the three and six months ended June 30, 2023 is as follows:

 

  

Shares

  

Fair Value

 

Weighted Average Fair Value

 

(In thousands)

  

Per Share

 

Unvested, December 31, 2022

  193  $1.74 

Granted

    $ 

Vested

  (122) $1.71 

Forfeited or canceled

    $ 

Unvested, June 30, 2023

  72  $1.79 

 

As of June 30, 2023, the total unrecognized compensation cost related to stock compensation expense for restricted stock is $0.1 million, expected to be recognized over a weighted average period of 0.5 years.

 

2020 Plan

 

In June 2020, the Company’s board of directors adopted the 2020 Stock Option and Incentive Plan (the “2020 Plan”) and reserved 2.9 million shares of common stock for issuance under this plan. The 2020 Plan includes automatic annual increases. The increase on January 1, 2023 was 5.1 million shares. As of June 30, 2023, 5.2 million shares remain available for grant.

 

The 2020 Plan authorizes the board of directors or a committee of the board to grant incentive stock options, nonqualified stock options, restricted stock awards and restricted stock units ("RSUs") to eligible officers, employees, consultants and directors of the Company. Options generally vest over a period of four years and have a contractual life of ten years from the date of grant.

 

Stock Options:

 

The following table summarizes the stock option activity for the 2020 Plan:

 

      

Weighted

  

Weighted

     
  

Number of

  

Average

  

Average

  

Aggregate

 
  

Unvested

  

Exercise

  

Remaining

  

Intrinsic

 
  

Options

  

Price

  

Contractual

  

Value

 
  

(In thousands)

  

Per Share

  

Term (In years)

  

(In thousands)

 

Outstanding at December 31, 2022

  5,378  $3.89   8.24  $6,316 

Granted

  2,613  $3.80   9.64     

Exercised

  (12) $2.43         

Forfeited/canceled

  (228) $4.75         

Outstanding at June 30, 2023

  7,751  $3.84   8.51  $1,814 

Vested at June 30, 2023

  3,233  $4.34   7.75  $569 

 

For the six months ended June 30, 2023, the weighted average grant date fair value for options granted was $2.85. The intrinsic value for options vested as of June 30, 2023, was $0.6 million. As of June 30, 2023, the total unrecognized compensation cost related to outstanding options was $11.3 million, to be recognized over a weighted average period of 3 years.

 

For the six months ended June 30, 2022, the weighted average grant date fair value for options granted was $2.29. The intrinsic value for options vested as of June 30, 2022, was $47 thousand.

 

The weighted average assumptions used in the Black-Scholes pricing model to determine the fair value of stock options granted during the six months ended June 30, 2023 and 2022 were as follows:

 

  

Six Months Ended June 30,

 
  

2023

  

2022

 

Expected term (in years)

  6.0   5.8 

Risk-free rate

  3.8%  1.9%

Expected volatility

  88%  90%

Expected dividend yield

      

 

As of January 2023, the Company used the historical price of only its own stock to determine the expected volatility. Prior to this, a group of industry peers including the Company’s stock price was used.

 

RSUs:

 

The following table summarizes the RSU activity for the 2020 Plan:

 

  

Shares
(In thousands)

  

Weighted
Average Price
Per Share

  

Weighted
Average Fair Value (In thousands)

 

Unvested, December 31, 2022

  900  $3.83  $3,447 

Granted

  900   3.93   3,537 

Vested

         

Forfeited or canceled

         

Unvested, June 30, 2023

  1,800  $3.88  $6,984 

 

The weighted average price per share is the weighted grant price based on the closing market price of each of the stock grants. The weighted average fair value is the weighted average share price times the number of shares.


As of June 30, 2023, remaining unrecognized compensation cost related to RSUs to be recognized in future periods totaled $5.9 million, which is expected to be recognized over a weighted average period of 3 years.